About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
DELIVERABLE VOLUME
Deliverable
Volume
Astrazeneca Pharma India Ltd.
BSE Code
506820
ISIN Demat
INE203A01020
Book Value
319.60
NSE Code
ASTRAZEN
Dividend Yield %
0.35
Market Cap
225958.75
P/E
113.46
EPS
79.66
Face Value
2
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Total Volume
Deliverable Volume
Deliverable Volume [%]
26-Dec-2025
389
199
51.16
24-Dec-2025
51
40
78.43
23-Dec-2025
150
81
54.00
22-Dec-2025
67
54
80.60
19-Dec-2025
165
110
66.67
18-Dec-2025
235
156
66.38
17-Dec-2025
57
33
57.89
16-Dec-2025
88
54
61.36
15-Dec-2025
118
61
51.69
12-Dec-2025
103
40
38.83
11-Dec-2025
374
242
64.71
10-Dec-2025
108
67
62.04
09-Dec-2025
418
107
25.60
08-Dec-2025
155
76
49.03
05-Dec-2025
70
41
58.57
04-Dec-2025
187
97
51.87
03-Dec-2025
79
40
50.63
02-Dec-2025
518
366
70.66
01-Dec-2025
357
154
43.14
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.